Dermatology OTC Medications Market Size & Growth | 2021, 28

Dermatology OTC Medications Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Tablets and Capsules, Gels, Creams and Ointments, and Others), Route of Administration (Topical and Oral), Indication (Dermatitis, Acne, Psoriasis, Skin Bleaching, Fungal Disease, Warts, and Others), and Distribution Channel (Online Distribution and Offline Distribution)

  • Report Code : TIPRE00010460
  • Category : Life Sciences
  • Status : Published
  • No. of Pages : 279
Buy Now

Dermatology OTC Medications Market Size & Growth | 2021, 28

Buy Now

[Research Report] The dermatology OTC medications market is expected to grow from US$ 15,456.63 million in 2021 to US$ 21,313.40 million by 2028; it is estimated to grow at a CAGR of 4.7% from 2021 to 2028.  

Dermatology OTC medicines are directly sold to the consumer without a prescription from a healthcare professional, as opposed to prescription drugs, which may be sold only to consumers possessing a valid prescription. OTC drugs are selected by a regulatory agency to ensure that they contain ingredients that are safe and effective when used without a physician's care. OTC drugs are usually regulated according to their active pharmaceutical ingredient (API) rather than final products. By regulating APIs instead of specific drug formulations, governments allow manufacturers the freedom to formulate ingredients, or combinations of ingredients, into proprietary mixtures.

The dermatology OTC medications market is segmented based on product type, route of administration, indication, distribution channel, and geography. By geography, the market is broadly segmented into North America, Europe, Asia Pacific, the Middle East and Africa (MEA), and South and Central America. The report offers insights and in-depth analysis of the market, emphasizing parameters, such as market trends, technological advancements, and market dynamics, along with the analysis of the competitive landscape of the world's leading market players.     


Customize Research To Suit Your Requirement

We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.

Get 10% FREE CUSTOMIZATION

Dermatology OTC Medications Market: Strategic Insights

dermatology-otc-medications-market
Market Size Value inUS$ 15,456.63 Million in 2021
Market Size Value byUS$ 21,313.40 Million by 2028
Growth rateCAGR of 4.7% from 2021 to 2028
Forecast Period2021-2028
Base Year2021
Analyst Image

Mrinal

Have a question?

Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Analyst Image  Speak to Analyst

 

Market Insights

High Prevalence of Skin Problems Drives Dermatology OTC Medications Market Growth

The high prevalence of skin problems and rising income of the middle-class population are expected to boost the global market growth. However, the inappropriate use of OTC medications is restraining the growth of the dermatology OTC medications market. Skin issues, such as pigmentation, wrinkles, creases, acne, and burn scars, are common among people. According to the American Academy of Dermatology Association (AADA), acne is the most common skin condition in the US, affecting ~50 million Americans annually. Additionally, ~85% of people from ages 12 to 24 experience minor acne problems. The costs associated with acne treatment and lost productivity among those receiving acne treatment exceeded US$ ~1.2 billion in 2013; more than ~5.1 million people, primarily children and young adults were seeking medical treatment for acne in the same year. Further, 1 in 10 people develops atopic dermatitis, and it affects up to 25% of children and 2–3% of adults, as per the AADA. In 2021, according to a poll conducted by Dermstore with 2,000 women across the US, young women started using products to reduce the signs of aging much sooner than older women. Further, the European Commission (EC) has ranked skin diseases as the fourth most common cause of human illness. Acne vulgaris is becoming more prevalent in several countries. Dermatology OTC medications are widely used in the treatment of acne. Understanding the characteristics of acne vulgaris burden is critical for developing effective and targeted acne control therapies. According to the Global Burden of Disease Study 2019, 117.4 million incident cases of acne vulgaris, 231.2 million prevalent cases, and 5 million disability-adjusted life years (DALYs) were reported worldwide, representing a 48% increase since 1990.

Growing Awareness of Skin Diseases Contributes Significantly to Market Growth

Skin diseases significantly impact people's quality of life in developing countries, resulting in decreased productivity at work and school and discrimination due to disfigurement. Changes in the skin could also indicate the existence of more serious disorders that require treatment. Previously, such illnesses were overlooked or given little importance by health officials because they were not life-threatening in most cases, and they were rarely seen in tertiary care centers.

Currently, national and international healthcare centers have to train healthcare workers in developing countries to improve the diagnosis and treatment of dermatological conditions.

The American Academy of Dermatology (AAD) has launched several public awareness programs to improve the appearance of skin, hair, and nails. For example, October is Eczema Awareness Month, and the AAD offers dermatologist-approved information to help people better understand and manage their eczema. The American Skin Associations (ASA) funding options for 2021 are now available to support outstanding dermatological researchers and physicians. Over the last 34 years, ASA supported hundreds of grants that have resulted in important dermatological breakthroughs and better awareness and knowledge of skin conditions. Thus, the rising awareness of skin diseases supports the dermatology OTC medications market growth.

Product Type Insights

Based on product type, the global dermatology OTC medications market is segmented into tablets and capsules, gels, creams and ointments, and others. The creams and ointments segment held the largest share of the market in 2021. However, the tablets and capsules segment is anticipated to register the highest CAGR during the forecast period.

Route of Administration Insights

Based on route of administration, the dermatology OTC medications market is bifurcated into topical and oral. The topical segment held a larger share of the market in 2021; however, the oral segment is estimated to register a higher CAGR during the forecast period.

Indication Insights

Based on indication, the dermatology OTC medications market is segmented into dermatitis, acne, psoriasis, skin bleaching, fungal disease, warts, and others. The acne segment held the largest share of the market in 2021; it is estimated to register the highest CAGR during the forecast period.

Distribution Channel Insights

Based on distribution channel, the dermatology OTC medications market is bifurcated into online distribution and offline distribution. The offline distribution segment held a larger share of the market in 2021; however, the online distribution segment is estimated to register a higher CAGR during the forecast period. Furthermore, the offline distribution segment is bifurcated into retail & hospital pharmacies and super & hyper markets. The retail & hospital pharmacies segment held a larger share of the market in 2021.

Product launches, mergers, and acquisitions are the highly adopted strategies by the players operating in the global dermatology OTC medications market. A few of the recent key product developments are listed below:

In August 2020, Perrigo Company plc, a leading global provider of quality and affordable self-care products, announced that it acquired three Eastern European OTC skincare and hair loss treatment brands (Emolium, Iwostin, and Loxon) from Sanofi.

In April 2018, Sol-Gel Technologies Ltd. a clinical-stage dermatology company focused on identifying, developing, and commercializing branded and generic topical drug products for the treatment of skin diseases announced it has collaborated with Perrigo Israel, an affiliate of Perrigo Company plc, for the development, manufacturing, and commercialization of a generic product candidate.

The  COVID-19  pandemic  has brought about a significant burden on the healthcare industry globally. As the world slowly recovers, the way businesses are conducted will never be the same. COVID-19 has altered the corporate landscape in general. Several companies have experienced severe losses in the last quarter of 2019 and negatively influenced the first and second quarters of 2020. Research and development activities to identify the threat of the SARS-CoV-2 virus on the patients suffering are likely to slow the dermatology OTC medication market growth. Hence, the impact of the COVID-19 pandemic on the dermatology OTC medications market was immediate and drastic. The demand for dermatology OTC medications is reduced due to the COVID-19 outbreak, as the focus of healthcare shifted toward saving lives. The COVID-19 pandemic is causing massive disruptions in global supply chains, consumer markets, and the global economy. As a result of the measures implemented by governments worldwide, there is a risk of a temporary and significant decline in demand for dermatology OTC medications. Therefore, the pandemic has adversely affected the dermatology OTC medications market.

Dermatology OTC Medications – Market Segmentation

The global dermatology OTC medications market is segmented on the basis of type, technology, services, and geography. Based on product type, market has been sub segmented into tablets and capsules, gels, creams and ointments, and others.. Based on route of administration, the dermatology OTC medications market is bifurcated into topical and oral. Based on indication, the dermatology OTC medications market is segmented into dermatitis, acne, psoriasis, skin bleaching, fungal disease, warts, and others. Based on distribution channel, the market is bifurcated into online distribution and offline distribution.The dermatology OTC medications market, by geography, is broadly segmented into North America, Europe, Asia Pacific, the Middle East & Africa, and South and Central America.

Dermatology OTC Medications Market Report Scope

 

Company Profiles

  • Bausch Health Companies Inc.
  • Perrigo Company plc
  • Bayer AG
  • Viatris Inc.
  • Johnson and Johnson Services, Inc.
  • LEO Pharma A/S
  • GlaxoSmithKline plc.
  • Galderma
  • Dr. Reddy's Laboratories
  • ACELLA PHARMACEUTICALS, LLC
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

Product Type, Route of Administration, Indication, and Distribution Channel

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

Argentina, Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, Saudi Arabia, South Africa, South Korea, Spain, United Arab Emirates, United Kingdom, United States

Frequently Asked Questions

Who are the major players in the dermatology OTC medications market?

The dermatology OTC medications market majorly consists of the players such as, Bausch Health Companies Inc.; Perrigo Company plc; Bayer AG; Viatris Inc.; Johnson and Johnson Services, Inc.; LEO Pharma A/S; GlaxoSmithKline plc.; Galderma; Dr. Reddy's Laboratories; and Acella Pharmaceuticals, LLC.

What is dermatology OTC medications market?

Dermatology OTC medicines are directly sold by pharmacies and drug stores without the prescription from the physicians, as opposed to the drugs prescribed and maybe only sold to consumers who hold a valid prescription.

What are the factors impacting for the dermatology OTC medications market?

Several factors are believed to affect dermatology OTC medications market in the coming years. Factors such as high prevalence of skin problems and rising income of middle-class population are expected to boost the dermatology OTC medications market. However, the market is likely to get impacted by inappropriate use of OTC medications during the forecast period.

Which is the most influencing segment growing in the dermatology OTC medications report?

The global dermatology OTC medications market-based product type, market is categorized into tablets & capsules, gels, creams & ointments, and others. The creams and ointments segment held the largest share of the market in 2021. However, the tablets and capsules segment is anticipated to register the highest CAGR during the forecast period.

What is the market value of dermatology OTC medications market based on region?

The global dermatology OTC medications market is segmented into North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America. The US holds the largest share of the market in this region. The market growth in the country is attributed to the increase in skin abnormalities and the rise of availability of medication for dermatology over the counter (OTC) in the region.
The Asia Pacific region is expected to account for the fastest growth in the dermatology OTC medications market. In Japan, India and South Korea, the market is expected to grow owing to the ongoing research activities related to dermatology OTC products in the region.

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 Global Dermatology OTC Medications Market – By Product Type

1.3.2 Global Dermatology OTC Medications Market – By Route of Administration

1.3.3 Global Dermatology OTC Medications Market – By Indication

1.3.4 Global Dermatology OTC Medications Market – By Distribution Channel

1.3.5 Global Dermatology OTC Medications Market – By Geography

2. Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Dermatology OTC Medications Market – Market Landscape

4.1 Overview

4.2 PEST Analysis

4.2.1 North America PEST Analysis

4.2.2 Europe PEST Analysis

4.2.3 Asia Pacific PEST Analysis

4.2.4 Middle East And Africa PEST Analysis

4.2.5 South & Central America PEST Analysis

4.3 Experts Opinion

5. Dermatology OTC Medications Market – Key Market Dynamics

5.1 Key Market Drivers

5.1.1 High Prevalence of Skin Problems

5.1.2 Rising Income of Middle-Class Population

5.2 Market Restraints

5.2.1 Inappropriate Use of OTC Medications

5.3 Market Opportunities

5.3.1 Growing OTC Market

5.4 Future Trends

5.4.1 Transition from Rx to OTC

5.5 Impact Analysis of Drivers and Restraints

6. Dermatology OTC Medications Market– Global Analysis

6.1 Global Dermatology OTC Medications Market Revenue Forecast and Analysis

6.2 Global Dermatology OTC Medications Market, By Geography - Forecast and Analysis

6.3 Market Positioning of Key Players

7. Dermatology OTC Medications Market Analysis – By Product Type

7.1 Overview

7.2 Dermatology OTC Medications Market Share by Product Type, 2021 & 2028 (%)

7.3 Tablets and Capsules

7.3.1 Overview

7.3.2 Tablets and Capsules Market Revenue and Forecast to 2028 (US$ million)

7.4 Gels

7.4.1 Overview

7.4.2 Gels Market Revenue and Forecast to 2028 (US$ million)

7.5 Creams and Ointments

7.5.1 Overview

7.5.2 Creams and Ointments Market Revenue and Forecast to 2028 (US$ million)

7.6 Others

7.6.1 Overview

7.6.2 Others Market Revenue and Forecast to 2028 (US$ million)

8. Dermatology OTC medications Market Analysis – By Route of Administration

8.1 Overview

8.2 Dermatology OTC Medications Market Share, by Route of Administration, 2021 and 2028 (%)

8.3 Topical

8.3.1 Overview

8.3.2 Topical: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

8.4 Oral

8.4.1 Overview

8.4.2 Oral: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

9. Dermatology OTC Medications Market Analysis – By Indication

9.1 Overview

9.2 Dermatology OTC Medications Market Share, by Indication, 2021 and 2028 (%)

9.3 Dermatitis

9.3.1 Overview

9.3.2 Dermatitis: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

9.3.3 Atopic Dermatitis

9.3.3.1 Overview

9.3.3.2 Atopic Dermatitis: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

9.3.4 Contact Dermatitis

9.3.4.1 Overview

9.3.4.2 Contact Dermatitis: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

9.3.5 Others

9.3.5.1 Overview

9.3.5.2 Others: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

9.4 Acne

9.4.1 Overview

9.4.2 Acne: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

9.4.3 Non-Inflammatory Acne

9.4.3.1 Overview

9.4.3.2 Non-Inflammatory Acne: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

9.4.4 Inflammatory Acne

9.4.4.1 Overview

9.4.4.2 Inflammatory Acne: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

9.5 Psoriasis

9.5.1 Overview

9.5.2 Psoriasis: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

9.5.3 Plaque Psoriasis

9.5.3.1 Overview

9.5.3.2 Plaque Psoriasis: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

9.5.4 Guttate Psoriasis

9.5.4.1 Overview

9.5.4.2 Guttate Psoriasis: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

9.5.5 Others

9.5.5.1 Overview

9.5.5.2 Others: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

9.6 Skin Bleaching

9.6.1 Overview

9.6.2 Skin Bleaching: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

9.7 Fungal Disease

9.7.1 Overview

9.7.2 Fungal Disease: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

9.7.3 Athlete's Foot

9.7.3.1 Overview

9.7.3.2 Athlete's Foot: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

9.7.4 Ringworm

9.7.4.1 Overview

9.7.4.2 Ringworm: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

9.7.5 Fungal Nail Infections

9.7.5.1 Overview

9.7.5.2 Fungal Nail Infections: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

9.7.6 Others

9.7.6.1 Overview

9.7.6.2 Others: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

9.8 Warts

9.8.1 Overview

9.8.2 Warts: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

9.8.3 Common Warts

9.8.3.1 Overview

9.8.3.2 Common Warts: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

9.8.4 Flat Warts

9.8.4.1 Overview

9.8.4.2 Flat Warts: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

9.8.5 Others

9.8.5.1 Overview

9.8.5.2 Others: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

9.9 Others

9.9.1 Overview

9.9.2 Others: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

10. Dermatology OTC medications Market Analysis – By Distribution Channel

10.1 Overview

10.2 Dermatology OTC Medications Market Share, by Distribution Channel, 2021 and 2028 (%)

10.3 Online Distribution

10.3.1 Overview

10.3.2 Online Distribution: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

10.4 Offline Distribution

10.4.1 Overview

10.4.2 Offline Distribution: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

10.4.3 Retail and Hospital Pharmacies

10.4.3.1 Overview

10.4.3.2 Retail and Hospital Pharmacies: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

10.4.4 Super and Hyper Markets

10.4.4.1 Overview

10.4.4.2 Super and Hyper Markets: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

11. Dermatology OTC Medications Market Revenue and Forecasts to 2028 – Geographical Analysis

11.1 North America Dermatology OTC Medications Market Revenue and Forecasts To 2028

11.1.1 Overview

11.1.2 North America: Dermatology OTC Medications – Revenue and Forecast to 2028 (USD Million)

11.1.3 North America: Dermatology OTC Medications Market, by Product Type, 2019–2028 (USD Million)

11.1.4 North America: Dermatology OTC Medications Market, by Route of Administration, 2019–2028 (USD Million)

11.1.5 North America: Dermatology OTC Medications Market, by Indication, 2019–2028 (USD Million)

11.1.5.1 North America: Dermatology OTC Medications Market, by Dermatitis, 2019–2028 (USD Million)

11.1.5.2 North America: Dermatology OTC Medications Market, by Acne, 2019–2028 (USD Million)

11.1.5.3 North America: Dermatology OTC Medications Market, by Psoriasis, 2019–2028 (USD Million)

11.1.5.4 North America: Dermatology OTC Medications Market, by Fungal Disease, 2019–2028 (USD Million)

11.1.5.5 North America: Dermatology OTC Medications Market, by Warts, 2019–2028 (USD Million)

11.1.6 North America: Dermatology OTC Medications Market, by Distribution Channel, 2019–2028 (USD Million)

11.1.6.1 North America: Dermatology OTC Medications Market, by Offline Distribution, 2019–2028 (USD Million)

11.1.7 North America Dermatology OTC Medications Market, by Country, 2021 & 2028 (%)

11.1.8 US: Dermatology OTC Medications Market – Revenue and Forecast to 2028 (USD Million)

11.1.8.1 Overview

11.1.8.2 US: Dermatology OTC Medications Market – Revenue and Forecast to 2028 (USD Million)

11.1.8.3 US: Dermatology OTC Medications Market, by Product Type, 2019–2028 (USD Million)

11.1.8.4 US: Dermatology OTC Medications Market, by Route of Administration, 2019–2028 (USD Million)

11.1.8.5 US: Dermatology OTC Medications Market, by Indication, 2019–2028 (USD Million)

11.1.8.5.1 US: Dermatology OTC Medications Market, by Dermatitis, 2019–2028 (USD Million)

11.1.8.5.2 US: Dermatology OTC Medications Market, by Acne, 2019–2028 (USD Million)

11.1.8.5.3 US: Dermatology OTC Medications Market, by Psoriasis, 2019–2028 (USD Million)

11.1.8.5.4 US: Dermatology OTC Medications Market, by Fungal Disease, 2019–2028 (USD Million)

11.1.8.5.5 US: Dermatology OTC Medications Market, by Warts, 2019–2028 (USD Million)

11.1.8.6 US: Dermatology OTC Medications Market, by Distribution Channel, 2019–2028 (USD Million)

11.1.8.6.1 US: Dermatology OTC Medications Market, by Offline Distribution, 2019–2028 (USD Million)

11.1.9 Canada: Dermatology OTC Medications Market – Revenue and Forecast to 2028 (USD Million)

11.1.9.1 Overview

11.1.9.2 Canada: Dermatology OTC Medications Market – Revenue and Forecast to 2028 (USD Million)

11.1.9.3 Canada: Dermatology OTC Medications Market, by Product Type, 2019–2028 (USD Million)

11.1.9.4 Canada: Dermatology OTC Medications Market, by Route of Administration, 2019–2028 (USD Million)

11.1.9.5 Canada: Dermatology OTC Medications Market, by Indication, 2019–2028 (USD Million)

11.1.9.5.1 Canada: Dermatology OTC Medications Market, by Dermatitis, 2019–2028 (USD Million)

11.1.9.5.2 Canada: Dermatology OTC Medications Market, by Acne, 2019–2028 (USD Million)

11.1.9.5.3 Canada: Dermatology OTC Medications Market, by Psoriasis, 2019–2028 (USD Million)

11.1.9.5.4 Canada: Dermatology OTC Medications Market, by Fungal Disease, 2019–2028 (USD Million)

11.1.9.5.5 Canada: Dermatology OTC Medications Market, by Warts, 2019–2028 (USD Million)

11.1.9.6 Canada: Dermatology OTC Medications Market, by Distribution Channel, 2019–2028 (USD Million)

11.1.9.6.1 Canada: Dermatology OTC Medications Market, by Offline Distribution, 2019–2028 (USD Million)

11.1.10 Mexico: Dermatology OTC Medications Market – Revenue and Forecast to 2028 (USD Million)

11.1.10.1 Overview

11.1.10.2 Mexico: Dermatology OTC Medications Market – Revenue and Forecast to 2028 (USD Million)

11.1.10.3 Mexico: Dermatology OTC Medications Market, by Product Type, 2019–2028 (USD Million)

11.1.10.4 Mexico: Dermatology OTC Medications Market, by Route of Administration, 2019–2028 (USD Million)

11.1.10.5 Mexico: Dermatology OTC Medications Market, by Indication, 2019–2028 (USD Million)

11.1.10.5.1 Mexico: Dermatology OTC Medications Market, by Dermatitis, 2019–2028 (USD Million)

11.1.10.5.2 Mexico: Dermatology OTC Medications Market, by Acne, 2019–2028 (USD Million)

11.1.10.5.3 Mexico: Dermatology OTC Medications Market, by Psoriasis, 2019–2028 (USD Million)

11.1.10.5.4 Mexico: Dermatology OTC Medications Market, by Fungal Disease, 2019–2028 (USD Million)

11.1.10.5.5 Mexico: Dermatology OTC Medications Market, by Warts, 2019–2028 (USD Million)

11.1.10.6 Mexico: Dermatology OTC Medications Market, by Distribution Channel, 2019–2028 (USD Million)

11.1.10.6.1 Mexico: Dermatology OTC Medications Market, by Offline Distribution, 2019–2028 (USD Million)

11.2 Europe Dermatology OTC Medications Market Revenue and Forecasts To 2028

11.2.1 Overview

11.2.2 Europe: Dermatology OTC Medications – Revenue and Forecast to 2028 (USD Million)

11.2.3 Europe: Dermatology OTC Medications Market, by Product Type, 2019–2028 (USD Million)

11.2.4 Europe: Dermatology OTC Medications Market, by Route of Administration, 2019–2028 (USD Million)

11.2.5 Europe: Dermatology OTC Medications Market, by Indication, 2019–2028 (USD Million)

11.2.5.1 Europe: Dermatology OTC Medications Market, by Dermatitis, 2019–2028 (USD Million)

11.2.5.2 Europe: Dermatology OTC Medications Market, by Acne, 2019–2028 (USD Million)

11.2.5.3 Europe: Dermatology OTC Medications Market, by Psoriasis, 2019–2028 (USD Million)

11.2.5.4 Europe: Dermatology OTC Medications Market, by Fungal Disease, 2019–2028 (USD Million)

11.2.5.5 Europe: Dermatology OTC Medications Market, by Warts, 2019–2028 (USD Million)

11.2.6 Europe: Dermatology OTC Medications Market, by Distribution Channel, 2019–2028 (USD Million)

11.2.6.1 Europe: Dermatology OTC Medications Market, by Offline Distribution, 2019–2028 (USD Million)

11.2.7 Europe: Dermatology OTC Medications Market, by Country, 2021 & 2028 (%)

11.2.8 Germany: Dermatology OTC Medications Market – Revenue and Forecast to 2028 (USD Million)

11.2.8.1 Overview

11.2.8.2 Germany: Dermatology OTC Medications Market – Revenue and Forecast to 2028 (USD Million)

11.2.8.3 Germany: Dermatology OTC Medications Market, by Product Type, 2019–2028 (USD Million)

11.2.8.4 Germany: Dermatology OTC Medications Market, by Route of Administration, 2019–2028 (USD Million)

11.2.8.5 Germany: Dermatology OTC Medications Market, by Indication, 2019–2028 (USD Million)

11.2.8.5.1 Germany: Dermatology OTC Medications Market, by Dermatitis, 2019–2028 (USD Million)

11.2.8.5.2 Germany: Dermatology OTC Medications Market, by Acne, 2019–2028 (USD Million)

11.2.8.5.3 Germany: Dermatology OTC Medications Market, by Psoriasis, 2019–2028 (USD Million)

11.2.8.5.4 Germany: Dermatology OTC Medications Market, by Fungal Disease, 2019–2028 (USD Million)

11.2.8.5.5 Germany: Dermatology OTC Medications Market, by Warts, 2019–2028 (USD Million)

11.2.8.6 Germany: Dermatology OTC Medications Market, by Distribution Channel, 2019–2028 (USD Million)

11.2.8.6.1 Germany: Dermatology OTC Medications Market, by Offline Distribution, 2019–2028 (USD Million)

11.2.9 France: Dermatology OTC Medications Market – Revenue and Forecast to 2028 (USD Million)

11.2.9.1 Overview

11.2.9.2 France: Dermatology OTC Medications Market – Revenue and Forecast to 2028 (USD Million)

11.2.9.3 France: Dermatology OTC Medications Market, by Product Type, 2019–2028 (USD Million)

11.2.9.4 France: Dermatology OTC Medications Market, by Route of Administration, 2019–2028 (USD Million)

11.2.9.5 France: Dermatology OTC Medications Market, by Indication, 2019–2028 (USD Million)

11.2.9.5.1 France: Dermatology OTC Medications Market, by Dermatitis, 2019–2028 (USD Million)

11.2.9.5.2 France: Dermatology OTC Medications Market, by Acne, 2019–2028 (USD Million)

11.2.9.5.3 France: Dermatology OTC Medications Market, by Psoriasis, 2019–2028 (USD Million)

11.2.9.5.4 France: Dermatology OTC Medications Market, by Fungal Disease, 2019–2028 (USD Million)

11.2.9.5.5 France: Dermatology OTC Medications Market, by Warts, 2019–2028 (USD Million)

11.2.9.6 France: Dermatology OTC Medications Market, by Distribution Channel, 2019–2028 (USD Million)

11.2.9.6.1 France: Dermatology OTC Medications Market, by Offline Distribution, 2019–2028 (USD Million)

11.2.10 UK: Dermatology OTC Medications Market – Revenue and Forecast to 2028 (USD Million)

11.2.10.1 Overview

11.2.10.2 UK: Dermatology OTC Medications Market – Revenue and Forecast to 2028 (USD Million)

11.2.10.3 UK: Dermatology OTC Medications Market, by Product Type, 2019–2028 (USD Million)

11.2.10.4 UK: Dermatology OTC Medications Market, by Route of Administration, 2019–2028 (USD Million)

11.2.10.5 UK: Dermatology OTC Medications Market, by Indication, 2019–2028 (USD Million)

11.2.10.5.1 UK: Dermatology OTC Medications Market, by Dermatitis, 2019–2028 (USD Million)

11.2.10.5.2 UK: Dermatology OTC Medications Market, by Acne, 2019–2028 (USD Million)

11.2.10.5.3 UK: Dermatology OTC Medications Market, by Psoriasis, 2019–2028 (USD Million)

11.2.10.5.4 UK: Dermatology OTC Medications Market, by Fungal Disease, 2019–2028 (USD Million)

11.2.10.5.5 UK: Dermatology OTC Medications Market, by Warts, 2019–2028 (USD Million)

11.2.10.6 UK: Dermatology OTC Medications Market, by Distribution Channel, 2019–2028 (USD Million)

11.2.10.6.1 UK: Dermatology OTC Medications Market, by Offline Distribution, 2019–2028 (USD Million)

11.2.11 Italy: Dermatology OTC Medications Market – Revenue and Forecast to 2028 (USD Million)

11.2.11.1 Overview

11.2.11.2 Italy: Dermatology OTC Medications Market – Revenue and Forecast to 2028 (USD Million)

11.2.11.3 Italy: Dermatology OTC Medications Market, by Product Type, 2019–2028 (USD Million)

11.2.11.4 Italy: Dermatology OTC Medications Market, by Route of Administration, 2019–2028 (USD Million)

11.2.11.5 Italy: Dermatology OTC Medications Market, by Indication, 2019–2028 (USD Million)

11.2.11.5.1 Italy: Dermatology OTC Medications Market, by Dermatitis, 2019–2028 (USD Million)

11.2.11.5.2 Italy: Dermatology OTC Medications Market, by Acne, 2019–2028 (USD Million)

11.2.11.5.3 Italy: Dermatology OTC Medications Market, by Psoriasis, 2019–2028 (USD Million)

11.2.11.5.4 Italy: Dermatology OTC Medications Market, by Fungal Disease, 2019–2028 (USD Million)

11.2.11.5.5 Italy: Dermatology OTC Medications Market, by Warts, 2019–2028 (USD Million)

11.2.11.6 Italy: Dermatology OTC Medications Market, by Distribution Channel, 2019–2028 (USD Million)

11.2.11.6.1 Italy: Dermatology OTC Medications Market, by Offline Distribution, 2019–2028 (USD Million)

11.2.12 Spain: Dermatology OTC Medications Market – Revenue and Forecast to 2028 (USD Million)

11.2.12.1 Overview

11.2.12.2 Spain: Dermatology OTC Medications Market – Revenue and Forecast to 2028 (USD Million)

11.2.12.3 Spain: Dermatology OTC Medications Market, by Product Type, 2019–2028 (USD Million)

11.2.12.4 Spain: Dermatology OTC Medications Market, by Route of Administration, 2019–2028 (USD Million)

11.2.12.5 Spain: Dermatology OTC Medications Market, by Indication, 2019–2028 (USD Million)

11.2.12.5.1 Spain: Dermatology OTC Medications Market, by Dermatitis, 2019–2028 (USD Million)

11.2.12.5.2 Spain: Dermatology OTC Medications Market, by Acne, 2019–2028 (USD Million)

11.2.12.5.3 Spain: Dermatology OTC Medications Market, by Psoriasis, 2019–2028 (USD Million)

11.2.12.5.4 Spain: Dermatology OTC Medications Market, by Fungal Disease, 2019–2028 (USD Million)

11.2.12.5.5 Spain: Dermatology OTC Medications Market, by Warts, 2019–2028 (USD Million)

11.2.12.6 Spain: Dermatology OTC Medications Market, by Distribution Channel, 2019–2028 (USD Million)

11.2.12.6.1 Spain: Dermatology OTC Medications Market, by Offline Distribution, 2019–2028 (USD Million)

11.2.13 Rest of Europe: Dermatology OTC Medications Market – Revenue and Forecast to 2028 (USD Million)

11.2.13.1 Overview

11.2.13.2 Rest of Europe: Dermatology OTC Medications Market – Revenue and Forecast to 2028 (USD Million)

11.2.13.3 Rest of Europe: Dermatology OTC Medications Market, by Product Type, 2019–2028 (USD Million)

11.2.13.4 Rest of Europe: Dermatology OTC Medications Market, by Route of Administration, 2019–2028 (USD Million)

11.2.13.5 Rest of Europe: Dermatology OTC Medications Market, by Indication, 2019–2028 (USD Million)

11.2.13.5.1 Rest of Europe: Dermatology OTC Medications Market, by Dermatitis, 2019–2028 (USD Million)

11.2.13.5.2 Rest of Europe: Dermatology OTC Medications Market, by Acne, 2019–2028 (USD Million)

11.2.13.5.3 Rest of Europe: Dermatology OTC Medications Market, by Psoriasis, 2019–2028 (USD Million)

11.2.13.5.4 Rest of Europe: Dermatology OTC Medications Market, by Fungal Disease, 2019–2028 (USD Million)

11.2.13.5.5 Rest of Europe: Dermatology OTC Medications Market, by Warts, 2019–2028 (USD Million)

11.2.13.6 Rest of Europe: Dermatology OTC Medications Market, by Distribution Channel, 2019–2028 (USD Million)

11.2.13.6.1 Rest of Europe: Dermatology OTC Medications Market, by Offline Distribution, 2019–2028 (USD Million)

11.3 Asia Pacific: Dermatology OTC Medications Market

11.3.1 Overview

11.3.2 Asia Pacific: Dermatology OTC Medications Market - Revenue and Forecast to 2028 (USD Million)

11.3.3 Asia Pacific: Dermatology OTC Medications Market, by Product Type, 2019–2028 (USD Million)

11.3.4 Asia Pacific: Dermatology OTC Medications Market, By Route of Administration,2019–2028 (USD Million)

11.3.5 Asia Pacific: Dermatology OTC Medications Market, By Indication, 2019–2028 (USD Million)

11.3.5.1 Asia Pacific: Dermatology OTC Medications Market, by Acne Indication, 2019–2028 (USD Million)

11.3.5.2 Asia Pacific: Dermatology OTC Medications Market, by Dermatitis Indication, 2019–2028 (USD Million)

11.3.5.3 Asia Pacific: Dermatology OTC Medications Market, by Fungal Diseases Indication, 2019–2028 (USD Million)

11.3.5.4 Asia Pacific: Dermatology OTC Medications Market, by Psoriasis Indication, 2019–2028 (USD Million)

11.3.5.5 Asia Pacific: Dermatology OTC Medications Market, by Warts Indication, 2019–2028 (USD Million)

11.3.6 Asia Pacific: Dermatology OTC Medications Market, By Distribution Channel, 2019–2028 (USD Million)

11.3.6.1 Asia Pacific: Dermatology OTC Medications Market, by Offline Distribution, 2019–2028 (USD Million)

11.3.7 Asia Pacific: Dermatology OTC Medications Market, by Country, 2021 & 2028 (%)

11.3.8 China: Dermatology OTC Medications Market – Revenue and Forecast to 2028 (USD Million)

11.3.8.1 China: Dermatology OTC Medications Market – Revenue and Forecast to 2028 (USD Million)

11.3.8.2 China: Dermatology OTC Medications Market, by Product Type, 2019–2028 (USD Million)

11.3.8.3 China: Dermatology OTC Medications Market, By Route of Administration,2019–2028 (USD Million)

11.3.8.4 China: Dermatology OTC Medications Market, By Indication, 2019–2028 (USD Million)

11.3.8.4.1 China: Dermatology OTC Medications Market, by Acne Indication, 2019–2028 (USD Million)

11.3.8.4.2 China: Dermatology OTC Medications Market, by Dermatitis Indication, 2019–2028 (USD Million)

11.3.8.4.3 China: Dermatology OTC Medications Market, by Fungal Diseases Indication, 2019–2028 (USD Million)

11.3.8.4.4 China: Dermatology OTC Medications Market, by Psoriasis Indication, 2019–2028 (USD Million)

11.3.8.4.5 China: Dermatology OTC Medications Market, by Warts Indication, 2019–2028 (USD Million)

11.3.8.5 China: Dermatology OTC Medications Market, By Distribution Channel, 2019–2028 (USD Million)

11.3.8.5.1 China: Dermatology OTC Medications Market, by Offline Distribution, 2019–2028 (USD Million)

11.3.9 Japan: Dermatology OTC Medications Market – Revenue and Forecast to 2028 (USD Million)

11.3.9.1 Japan: Dermatology OTC Medications Market – Revenue and Forecast to 2028 (USD Million)

11.3.9.2 Japan: Dermatology OTC Medications Market, by Product Type, 2019–2028 (USD Million)

11.3.9.3 Japan: Dermatology OTC Medications Market, By Route of Administration,2019–2028 (USD Million)

11.3.9.4 Japan: Dermatology OTC Medications Market, By Indication, 2019–2028 (USD Million)

11.3.9.4.1 Japan: Dermatology OTC Medications Market, by Acne Indication, 2019–2028 (USD Million)

11.3.9.4.2 Japan: Dermatology OTC Medications Market, by Dermatitis Indication, 2019–2028 (USD Million)

11.3.9.4.3 Japan: Dermatology OTC Medications Market, by Fungal Diseases Indication, 2019–2028 (USD Million)

11.3.9.4.4 Japan: Dermatology OTC Medications Market, by Psoriasis Indication, 2019–2028 (USD Million)

11.3.9.4.5 Japan: Dermatology OTC Medications Market, by Warts Indication, 2019–2028 (USD Million)

11.3.9.5 Japan: Dermatology OTC Medications Market, By Distribution Channel, 2019–2028 (USD Million)

11.3.9.5.1 Japan: Dermatology OTC Medications Market, by Offline Distribution, 2019–2028 (USD Million)

11.3.10 India: Dermatology OTC Medications Market – Revenue and Forecast to 2028 (USD Million)

11.3.10.1 India: Dermatology OTC Medications Market – Revenue and Forecast to 2028 (USD Million)

11.3.10.2 India: Dermatology OTC Medications Market, by Product Type, 2019–2028 (USD Million)

11.3.10.3 India: Dermatology OTC Medications Market, By Route of Administration,2019–2028 (USD Million)

11.3.10.3.1 India: Dermatology OTC Medications Market, By Indication, 2019–2028 (USD Million)

11.3.10.3.2 India: Dermatology OTC Medications Market, by Acne Indication, 2019–2028 (USD Million)

11.3.10.3.3 India: Dermatology OTC Medications Market, by Dermatitis Indication, 2019–2028 (USD Million)

11.3.10.3.4 India: Dermatology OTC Medications Market, by Fungal Diseases Indication, 2019–2028 (USD Million)

11.3.10.3.5 India: Dermatology OTC Medications Market, by Psoriasis Indication, 2019–2028 (USD Million)

11.3.10.3.6 India: Dermatology OTC Medications Market, by Warts Indication, 2019–2028 (USD Million)

11.3.10.4 India: Dermatology OTC Medications Market, By Distribution Channel, 2019–2028 (USD Million)

11.3.10.4.1 India: Dermatology OTC Medications Market, by Offline Distribution, 2019–2028 (USD Million)

11.3.11 Australia: Dermatology OTC Medications Market – Revenue and Forecast to 2028 (USD Million)

11.3.11.1 Australia: Dermatology OTC Medications Market – Revenue and Forecast to 2028 (USD Million)

11.3.11.2 Australia: Dermatology OTC Medications Market, by Product Type, 2019–2028 (USD Million)

11.3.11.3 Australia: Dermatology OTC Medications Market, By Route of Administration,2019–2028 (USD Million)

11.3.11.4 Australia: Dermatology OTC Medications Market, By Indication, 2019–2028 (USD Million)

11.3.11.4.1 Australia: Dermatology OTC Medications Market, by Acne Indication, 2019–2028 (USD Million)

11.3.11.4.2 Australia: Dermatology OTC Medications Market, by Dermatitis Indication, 2019–2028 (USD Million)

11.3.11.4.3 Australia: Dermatology OTC Medications Market, by Fungal Diseases Indication, 2019–2028 (USD Million)

11.3.11.4.4 Australia: Dermatology OTC Medications Market, by Psoriasis Indication, 2019–2028 (USD Million)

11.3.11.4.5 Australia: Dermatology OTC Medications Market, by Warts Indication, 2019–2028 (USD Million)

11.3.11.5 Australia: Dermatology OTC Medications Market, By Distribution Channel, 2019–2028 (USD Million)

11.3.11.5.1 Australia: Dermatology OTC Medications Market, by Offline Distribution, 2019–2028 (USD Million)

11.3.12 South Korea: Dermatology OTC Medications Market – Revenue and Forecast to 2028 (USD Million)

11.3.12.1 South Korea: Dermatology OTC Medications Market – Revenue and Forecast to 2028 (USD Million)

11.3.12.2 South Korea: Dermatology OTC Medications Market, by Product Type, 2019–2028 (USD Million)

11.3.12.3 South Korea: Dermatology OTC Medications Market, By Route of Administration,2019–2028 (USD Million)

11.3.12.4 South Korea: Dermatology OTC Medications Market, By Indication, 2019–2028 (USD Million)

11.3.12.4.1 South Korea: Dermatology OTC Medications Market, by Acne Indication, 2019–2028 (USD Million)

11.3.12.4.2 South Korea: Dermatology OTC Medications Market, by Dermatitis Indication, 2019–2028 (USD Million)

11.3.12.4.3 South Korea: Dermatology OTC Medications Market, by Fungal Diseases Indication, 2019–2028 (USD Million)

11.3.12.4.4 South Korea: Dermatology OTC Medications Market, by Psoriasis Indication, 2019–2028 (USD Million)

11.3.12.4.5 South Korea: Dermatology OTC Medications Market, by Warts Indication, 2019–2028 (USD Million)

11.3.12.5 South Korea: Dermatology OTC Medications Market, By Distribution Channel, 2019–2028 (USD Million)

11.3.12.5.1 South Korea: Dermatology OTC Medications Market, by Offline Distribution, 2019–2028 (USD Million)

11.3.13 Rest of Asia Pacific: Dermatology OTC Medications Market – Revenue and Forecast to 2028 (USD Million)

11.3.13.1 Rest of Asia Pacific: Dermatology OTC Medications Market – Revenue and Forecast to 2028 (USD Million)

11.3.13.2 Rest of Asia Pacific: Dermatology OTC Medications Market, by Product Type, 2019–2028 (USD Million)

11.3.13.3 Rest of Asia Pacific: Dermatology OTC Medications Market, By Route of Administration,2019–2028 (USD Million)

11.3.13.4 Rest of Asia Pacific: Dermatology OTC Medications Market, By Indication, 2019–2028 (USD Million)

11.3.13.4.1 Rest of Asia Pacific: Dermatology OTC Medications Market, by Acne Indication, 2019–2028 (USD Million)

11.3.13.4.2 Rest of Asia Pacific: Dermatology OTC Medications Market, by Dermatitis Indication, 2019–2028 (USD Million)

11.3.13.4.3 Rest of Asia Pacific: Dermatology OTC Medications Market, by Fungal Diseases Indication, 2019–2028 (USD Million)

11.3.13.4.4 Rest of Asia Pacific: Dermatology OTC Medications Market, by Psoriasis Indication, 2019–2028 (USD Million)

11.3.13.4.5 Rest of Asia Pacific: Dermatology OTC Medications Market, by Warts Indication, 2019–2028 (USD Million)

11.3.13.5 Rest of Asia Pacific: Dermatology OTC Medications Market, By Distribution Channel, 2019–2028 (USD Million)

11.3.13.5.1 Rest of Asia Pacific: Dermatology OTC Medications Market, by Offline Distribution, 2019–2028 (USD Million)

11.4 Middle East & Africa Medical Lasers Market Revenue and Forecasts To 2028

11.4.1 Overview

11.4.2 Middle East & Africa Dermatology OTC Medications Market Revenue and Forecasts to 2028 (US$ Million)

11.4.3 Middle East & Africa: Dermatology OTC Medications Market, by Product Type, 2019–2028 (USD Million)

11.4.4 Middle East & Africa: Dermatology OTC Medications Market, By Route of Administration,2019–2028 (USD Million)

11.4.5 Middle East & Africa: Dermatology OTC Medications Market, By Indication, 2019–2028 (USD Million)

11.4.5.1 Middle East & Africa: Dermatology OTC Medications Market, by Acne Indication, 2019–2028 (USD Million)

11.4.5.2 Middle East & Africa: Dermatology OTC Medications Market, by Dermatitis Indication, 2019–2028 (USD Million)

11.4.5.3 Middle East & Africa: Dermatology OTC Medications Market, by Fungal Diseases Indication, 2019–2028 (USD Million)

11.4.5.4 Middle East & Africa: Dermatology OTC Medications Market, by Psoriasis Indication, 2019–2028 (USD Million)

11.4.5.5 Middle East & Africa: Dermatology OTC Medications Market, by Warts Indication, 2019–2028 (USD Million)

11.4.6 Middle East & Africa: Dermatology OTC Medications Market, By Distribution Channel, 2019–2028 (USD Million)

11.4.6.1 Middle East & Africa: Dermatology OTC Medications Market, by Offline Distribution, 2019–2028 (USD Million)

11.4.7 Middle East & Africa Dermatology OTC Medications Market Revenue and Forecasts to 2028, By Country (%)

11.4.8 UAE: Dermatology OTC Medications Market Revenue and Forecasts to 2028 (US$ Million)

11.4.8.1 UAE: Dermatology OTC Medications Market Revenue and Forecasts to 2028 (US$ Million)

11.4.8.2 UAE: Dermatology OTC Medications Market, by Product Type, 2019–2028 (USD Million)

11.4.8.3 UAE: Dermatology OTC Medications Market, By Route of Administration,2019–2028 (USD Million)

11.4.8.4 UAE: Dermatology OTC Medications Market, By Indication, 2019–2028 (USD Million)

11.4.8.4.1 UAE: Dermatology OTC Medications Market, by Acne Indication, 2019–2028 (USD Million)

11.4.8.4.2 UAE: Dermatology OTC Medications Market, by Dermatitis Indication, 2019–2028 (USD Million)

11.4.8.4.3 UAE: Dermatology OTC Medications Market, by Fungal Diseases Indication, 2019–2028 (USD Million)

11.4.8.4.4 UAE: Dermatology OTC Medications Market, by Psoriasis Indication, 2019–2028 (USD Million)

11.4.8.4.5 UAE: Dermatology OTC Medications Market, by Warts Indication, 2019–2028 (USD Million)

11.4.8.5 UAE: Dermatology OTC Medications Market, By Distribution Channel, 2019–2028 (USD Million)

11.4.8.5.1 UAE: Dermatology OTC Medications Market, by Offline Distribution, 2019–2028 (USD Million)

11.4.9 Saudi Arabia: Dermatology OTC Medications Market Revenue and Forecasts to 2028 (US$ Million)

11.4.9.1 Saudi Arabia: Dermatology OTC Medications Market Revenue and Forecasts to 2028 (US$ Million)

11.4.9.2 Saudi Arabia: Dermatology OTC Medications Market, by Product Type, 2019–2028 (USD Million)

11.4.9.3 Saudi Arabia: Dermatology OTC Medications Market, By Route of Administration,2019–2028 (USD Million)

11.4.9.4 Saudi Arabia: Dermatology OTC Medications Market, By Indication, 2019–2028 (USD Million)

11.4.9.4.1 Saudi Arabia: Dermatology OTC Medications Market, by Acne Indication, 2019–2028 (USD Million)

11.4.9.4.2 Saudi Arabia: Dermatology OTC Medications Market, by Dermatitis Indication, 2019–2028 (USD Million)

11.4.9.4.3 Saudi Arabia: Dermatology OTC Medications Market, by Fungal Diseases Indication, 2019–2028 (USD Million)

11.4.9.4.4 Saudi Arabia: Dermatology OTC Medications Market, by Psoriasis Indication, 2019–2028 (USD Million)

11.4.9.4.5 Saudi Arabia: Dermatology OTC Medications Market, by Warts Indication, 2019–2028 (USD Million)

11.4.9.5 Saudi Arabia: Dermatology OTC Medications Market, By Distribution Channel, 2019–2028 (USD Million)

11.4.9.5.1 Saudi Arabia: Dermatology OTC Medications Market, by Offline Distribution, 2019–2028 (USD Million)

11.4.10 South Africa: Dermatology OTC Medications Market Revenue and Forecasts to 2028 (US$ Million)

11.4.10.1 South Africa Dermatology OTC Medications Market Revenue and Forecasts to 2028 (US$ Million)

11.4.10.2 South Africa: Dermatology OTC Medications Market, by Product Type, 2019–2028 (USD Million)

11.4.10.3 South Africa: Dermatology OTC Medications Market, By Route of Administration,2019–2028 (USD Million)

11.4.10.4 South Africa: Dermatology OTC Medications Market, By Indication, 2019–2028 (USD Million)

11.4.10.4.1 South Africa: Dermatology OTC Medications Market, by Acne Indication, 2019–2028 (USD Million)

11.4.10.4.2 South Africa: Dermatology OTC Medications Market, by Dermatitis Indication, 2019–2028 (USD Million)

11.4.10.4.3 South Africa: Dermatology OTC Medications Market, by Fungal Diseases Indication, 2019–2028 (USD Million)

11.4.10.4.4 South Africa: Dermatology OTC Medications Market, by Psoriasis Indication, 2019–2028 (USD Million)

11.4.10.4.5 South Africa: Dermatology OTC Medications Market, by Warts Indication, 2019–2028 (USD Million)

11.4.10.5 South Africa: Dermatology OTC Medications Market, By Distribution Channel, 2019–2028 (USD Million)

11.4.10.5.1 South Africa: Dermatology OTC Medications Market, by Offline Distribution, 2019–2028 (USD Million)

11.4.11 Rest of the Middle East and Africa: Dermatology OTC Medications Market Revenue and Forecasts to 2028 (US$ Million)

11.4.11.1 Rest of Middle East and Africa: Dermatology OTC Medications Market Revenue and Forecasts to 2028 (US$ Million)

11.4.11.2 Rest of Middle East and Africa: Dermatology OTC Medications Market, by Product Type, 2019–2028 (USD Million)

11.4.11.3 Rest of Middle East and Africa: Dermatology OTC Medications Market, By Route of Administration,2019–2028 (USD Million)

11.4.11.4 Rest of Middle East and Africa: Dermatology OTC Medications Market, By Indication, 2019–2028 (USD Million)

11.4.11.4.1 Rest of Middle East and Africa: Dermatology OTC Medications Market, by Acne Indication, 2019–2028 (USD Million)

11.4.11.4.2 Rest of Middle East and Africa: Dermatology OTC Medications Market, by Dermatitis Indication, 2019–2028 (USD Million)

11.4.11.4.3 Rest of Middle East and Africa: Dermatology OTC Medications Market, by Fungal Diseases Indication, 2019–2028 (USD Million)

11.4.11.4.4 Rest of Middle East and Africa: Dermatology OTC Medications Market, by Psoriasis Indication, 2019–2028 (USD Million)

11.4.11.4.5 Rest of Middle East and Africa: Dermatology OTC Medications Market, by Warts Indication, 2019–2028 (USD Million)

11.4.11.5 Rest of Middle East and Africa: Dermatology OTC Medications Market, By Distribution Channel, 2019–2028 (USD Million)

11.4.11.5.1 Rest of Middle East and Africa: Dermatology OTC Medications Market, by Offline Distribution, 2019–2028 (USD Million)

11.5 South & Central America: Dermatology OTC Medications Market Revenue and Forecasts To 2028

11.5.1 Overview

11.5.2 South & Central America: Dermatology OTC Medications – Revenue and Forecast to 2028 (USD Million)

11.5.3 South & Central America: Dermatology OTC Medications Market, by Product Type, 2019–2028 (USD Million)

11.5.4 South & Central America: Dermatology OTC Medications Market, by Route of Administration, 2019–2028 (USD Million)

11.5.5 South & Central America: Dermatology OTC Medications Market, by Indication, 2019–2028 (USD Million)

11.5.5.1 South & Central America: Dermatology OTC Medications Market, by Dermatitis, 2019–2028 (USD Million)

11.5.5.2 South & Central America: Dermatology OTC Medications Market, by Acne, 2019–2028 (USD Million)

11.5.5.3 South & Central America: Dermatology OTC Medications Market, by Psoriasis, 2019–2028 (USD Million)

11.5.5.4 South & Central America: Dermatology OTC Medications Market, by Fungal Disease, 2019–2028 (USD Million)

11.5.5.5 South & Central America: Dermatology OTC Medications Market, by Warts, 2019–2028 (USD Million)

11.5.6 South & Central America: Dermatology OTC Medications Market, by Distribution Channel, 2019–2028 (USD Million)

11.5.6.1 South & Central America: Dermatology OTC Medications Market, by Offline Distribution, 2019–2028 (USD Million)

11.5.7 South & Central America: Dermatology OTC Medications Market, by Country, 2021 & 2028 (%)

11.5.8 Brazil: Dermatology OTC Medications Market – Revenue and Forecast to 2028 (USD Million)

11.5.8.1 Overview

11.5.8.2 Brazil: Dermatology OTC Medications Market – Revenue and Forecast to 2028 (USD Million)

11.5.8.3 Brazil: Dermatology OTC Medications Market, by Product Type, 2019–2028 (USD Million)

11.5.8.4 Brazil: Dermatology OTC Medications Market, by Route of Administration, 2019–2028 (USD Million)

11.5.8.5 Brazil: Dermatology OTC Medications Market, by Indication, 2019–2028 (USD Million)

11.5.8.5.1 Brazil: Dermatology OTC Medications Market, by Dermatitis, 2019–2028 (USD Million)

11.5.8.5.2 Brazil: Dermatology OTC Medications Market, by Acne, 2019–2028 (USD Million)

11.5.8.5.3 Brazil: Dermatology OTC Medications Market, by Psoriasis, 2019–2028 (USD Million)

11.5.8.5.4 Brazil: Dermatology OTC Medications Market, by Fungal Disease, 2019–2028 (USD Million)

11.5.8.5.5 Brazil: Dermatology OTC Medications Market, by Warts, 2019–2028 (USD Million)

11.5.8.6 Brazil: Dermatology OTC Medications Market, by Distribution Channel, 2019–2028 (USD Million)

11.5.8.6.1 Brazil: Dermatology OTC Medications Market, by Offline Distribution, 2019–2028 (USD Million)

11.5.9 Argentina: Dermatology OTC Medications Market – Revenue and Forecast to 2028 (USD Million)

11.5.9.1 Overview

11.5.9.2 Argentina: Dermatology OTC Medications Market – Revenue and Forecast to 2028 (USD Million)

11.5.9.3 Argentina: Dermatology OTC Medications Market, by Product Type, 2019–2028 (USD Million)

11.5.9.4 Argentina: Dermatology OTC Medications Market, by Route of Administration, 2019–2028 (USD Million)

11.5.9.5 Argentina: Dermatology OTC Medications Market, by Indication, 2019–2028 (USD Million)

11.5.9.5.1 Argentina: Dermatology OTC Medications Market, by Dermatitis, 2019–2028 (USD Million)

11.5.9.5.2 Argentina: Dermatology OTC Medications Market, by Acne, 2019–2028 (USD Million)

11.5.9.5.3 Argentina: Dermatology OTC Medications Market, by Psoriasis, 2019–2028 (USD Million)

11.5.9.5.4 Argentina: Dermatology OTC Medications Market, by Fungal Disease, 2019–2028 (USD Million)

11.5.9.5.5 Argentina: Dermatology OTC Medications Market, by Warts, 2019–2028 (USD Million)

11.5.9.6 Argentina: Dermatology OTC Medications Market, by Distribution Channel, 2019–2028 (USD Million)

11.5.9.6.1 Argentina: Dermatology OTC Medications Market, by Offline Distribution, 2019–2028 (USD Million)

11.5.10 Rest of South & Central America: Dermatology OTC Medications Market – Revenue and Forecast to 2028 (USD Million)

11.5.10.1 Overview

11.5.10.2 Rest of South & Central America: Dermatology OTC Medications Market – Revenue and Forecast to 2028 (USD Million)

11.5.10.3 Rest of South & Central America: Dermatology OTC Medications Market, by Product Type, 2019–2028 (USD Million)

11.5.10.4 Rest of South & Central America: Dermatology OTC Medications Market, by Route of Administration, 2019–2028 (USD Million)

11.5.10.5 Rest of South & Central America: Dermatology OTC Medications Market, by Indication, 2019–2028 (USD Million)

11.5.10.5.1 Rest of South & Central America: Dermatology OTC Medications Market, by Dermatitis, 2019–2028 (USD Million)

11.5.10.5.2 Rest of South & Central America: Dermatology OTC Medications Market, by Acne, 2019–2028 (USD Million)

11.5.10.5.3 Rest of South & Central America: Dermatology OTC Medications Market, by Psoriasis, 2019–2028 (USD Million)

11.5.10.5.4 Rest of South & Central America: Dermatology OTC Medications Market, by Fungal Disease, 2019–2028 (USD Million)

11.5.10.5.5 Rest of South & Central America: Dermatology OTC Medications Market, by Warts, 2019–2028 (USD Million)

11.5.10.6 Rest of South & Central America: Dermatology OTC Medications Market, by Distribution Channel, 2019–2028 (USD Million)

11.5.10.6.1 Rest of South & Central America: Dermatology OTC Medications Market, by Offline Distribution, 2019–2028 (USD Million)

12. Impact Of COVID-19 Pandemic on Dermatology OTC Medications Market

12.1 North America: Impact Assessment of COVID-19 Pandemic

12.2 Europe: Impact Assessment Of COVID-19 Pandemic

12.3 Asia Pacific: Impact Assessment of COVID-19 Pandemic

12.4 Middle East and Africa: Impact Assessment of COVID-19 Pandemic

12.5 South & Central America: Impact Assessment of COVID-19 Pandemic

13. Dermatology OTC Medications Market –Industry Landscape

13.1 Overview

13.2 Growth Strategies in the Dermatology OTC Medications Market , 2021-2028

13.3 Inorganic Growth Strategies

13.3.1 Overview

13.4 Organic Growth Strategies

13.4.1 Overview

14. Company Profiles

14.1 Bausch Health Companies Inc.

14.1.1 Key Facts

14.1.2 Business Description

14.1.3 Products and Services

14.1.4 Financial Overview

14.1.5 SWOT Analysis

14.1.6 Key Developments

14.2 Perrigo Company plc

14.2.1 Key Facts

14.2.2 Business Description

14.2.3 Products and Services

14.2.4 Financial Overview

14.2.5 SWOT Analysis

14.2.6 Key Developments

14.3 Bayer AG

14.3.1 Key Facts

14.3.2 Business Description

14.3.3 Products and Services

14.3.4 Financial Overview

14.3.5 SWOT Analysis

14.3.6 Key Developments

14.4 Viatris Inc.

14.4.1 Key Facts

14.4.2 Business Description

14.4.3 Products and Services

14.4.4 Financial Overview

14.4.5 SWOT Analysis

14.4.6 Key Developments

14.5 Johnson and Johnson Services, Inc.

14.5.1 Key Facts

14.5.2 Business Description

14.5.3 Products and Services

14.5.4 Financial Overview

14.5.5 SWOT Analysis

14.5.6 Key Developments

14.6 LEO Pharma A/S

14.6.1 Key Facts

14.6.2 Business Description

14.6.3 Products and Services

14.6.4 Financial Overview

14.6.5 SWOT Analysis

14.6.6 Key Developments

14.7 GlaxoSmithKline plc.

14.7.1 Key Facts

14.7.2 Business Description

14.7.3 Products and Services

14.7.4 Financial Overview

14.7.5 SWOT Analysis

14.7.6 Key Developments

14.8 Galderma

14.8.1 Key Facts

14.8.2 Business Description

14.8.3 Products and Services

14.8.4 Financial Overview

14.8.5 SWOT Analysis

14.8.6 Key Developments

14.9 Dr. Reddy's Laboratories

14.9.1 Key Facts

14.9.2 Business Description

14.9.3 Products and Services

14.9.4 Financial Overview

14.9.5 SWOT Analysis

14.9.6 Key Developments

14.10 ACELLA PHARMACEUTICALS, LLC

14.10.1 Key Facts

14.10.2 Business Description

14.10.3 Products and Services

14.10.4 Financial Overview

14.10.5 SWOT Analysis

14.10.6 Key Developments

15. Appendix

15.1 Glossary of Terms

LIST OF TABLES

Table 1. North America: Dermatology OTC Medications Market, by Product Type – Revenue and Forecast to 2028 (USD Million)

Table 2. North America: Dermatology OTC Medications Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)

Table 3. North America: Dermatology OTC Medications Market, by Indication – Revenue and Forecast to 2028 (USD Million)

Table 4. North America: Dermatology OTC Medications Market, by Dermatitis – Revenue and Forecast to 2028 (USD Million)

Table 5. North America: Dermatology OTC Medications Market, by Acne – Revenue and Forecast to 2028 (USD Million)

Table 6. North America: Dermatology OTC Medications Market, by Psoriasis – Revenue and Forecast to 2028 (USD Million)

Table 7. North America: Dermatology OTC Medications Market, by Fungal Disease – Revenue and Forecast to 2028 (USD Million)

Table 8. North America: Dermatology OTC Medications Market, by Warts – Revenue and Forecast to 2028 (USD Million)

Table 9. North America: Dermatology OTC Medications Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 10. North America: Dermatology OTC Medications Market, by Offline Distribution – Revenue and Forecast to 2028 (USD Million)

Table 11. US: Dermatology OTC Medications Market, by Product Type – Revenue and Forecast to 2028 (USD Million)

Table 12. US: Dermatology OTC Medications Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)

Table 13. US: Dermatology OTC Medications Market, by Indication – Revenue and Forecast to 2028 (USD Million)

Table 14. US: Dermatology OTC Medications Market, by Dermatitis – Revenue and Forecast to 2028 (USD Million)

Table 15. US: Dermatology OTC Medications Market, by Acne – Revenue and Forecast to 2028 (USD Million)

Table 16. US: Dermatology OTC Medications Market, by Psoriasis – Revenue and Forecast to 2028 (USD Million)

Table 17. US: Dermatology OTC Medications Market, by Fungal Disease – Revenue and Forecast to 2028 (USD Million)

Table 18. US: Dermatology OTC Medications Market, by Warts – Revenue and Forecast to 2028 (USD Million)

Table 19. US: Dermatology OTC Medications Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 20. US: Dermatology OTC Medications Market, by Offline Distribution – Revenue and Forecast to 2028 (USD Million)

Table 21. Canada: Dermatology OTC Medications Market, by Product Type – Revenue and Forecast to 2028 (USD Million)

Table 22. Canada: Dermatology OTC Medications Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)

Table 23. Canada: Dermatology OTC Medications Market, by Indication – Revenue and Forecast to 2028 (USD Million)

Table 24. Canada: Dermatology OTC Medications Market, by Dermatitis – Revenue and Forecast to 2028 (USD Million)

Table 25. Canada: Dermatology OTC Medications Market, by Acne – Revenue and Forecast to 2028 (USD Million)

Table 26. Canada: Dermatology OTC Medications Market, by Psoriasis – Revenue and Forecast to 2028 (USD Million)

Table 27. Canada: Dermatology OTC Medications Market, by Fungal Disease – Revenue and Forecast to 2028 (USD Million)

Table 28. Canada: Dermatology OTC Medications Market, by Warts – Revenue and Forecast to 2028 (USD Million)

Table 29. Canada: Dermatology OTC Medications Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 30. Canada: Dermatology OTC Medications Market, by Offline Distribution – Revenue and Forecast to 2028 (USD Million)

Table 31. Mexico: Dermatology OTC Medications Market, by Product Type – Revenue and Forecast to 2028 (USD Million)

Table 32. Mexico: Dermatology OTC Medications Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)

Table 33. Mexico: Dermatology OTC Medications Market, by Indication – Revenue and Forecast to 2028 (USD Million)

Table 34. Mexico: Dermatology OTC Medications Market, by Dermatitis – Revenue and Forecast to 2028 (USD Million)

Table 35. Mexico: Dermatology OTC Medications Market, by Acne – Revenue and Forecast to 2028 (USD Million)

Table 36. Mexico: Dermatology OTC Medications Market, by Psoriasis – Revenue and Forecast to 2028 (USD Million)

Table 37. Mexico: Dermatology OTC Medications Market, by Fungal Disease – Revenue and Forecast to 2028 (USD Million)

Table 38. Mexico: Dermatology OTC Medications Market, by Warts – Revenue and Forecast to 2028 (USD Million)

Table 39. Mexico: Dermatology OTC Medications Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 40. Mexico: Dermatology OTC Medications Market, by Offline Distribution – Revenue and Forecast to 2028 (USD Million)

Table 41. Europe: Dermatology OTC Medications Market, by Product Type – Revenue and Forecast to 2028 (USD Million)

Table 42. Europe: Dermatology OTC Medications Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)

Table 43. Europe: Dermatology OTC Medications Market, by Indication – Revenue and Forecast to 2028 (USD Million)

Table 44. Europe: Dermatology OTC Medications Market, by Dermatitis – Revenue and Forecast to 2028 (USD Million)

Table 45. Europe: Dermatology OTC Medications Market, by Acne – Revenue and Forecast to 2028 (USD Million)

Table 46. Europe: Dermatology OTC Medications Market, by Psoriasis – Revenue and Forecast to 2028 (USD Million)

Table 47. Europe: Dermatology OTC Medications Market, by Fungal Disease – Revenue and Forecast to 2028 (USD Million)

Table 48. Europe: Dermatology OTC Medications Market, by Warts – Revenue and Forecast to 2028 (USD Million)

Table 49. Europe: Dermatology OTC Medications Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 50. Europe: Dermatology OTC Medications Market, by Offline Distribution – Revenue and Forecast to 2028 (USD Million)

Table 51. Germany: Dermatology OTC Medications Market, by Product Type – Revenue and Forecast to 2028 (USD Million)

Table 52. Germany: Dermatology OTC Medications Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)

Table 53. Germany: Dermatology OTC Medications Market, by Indication – Revenue and Forecast to 2028 (USD Million)

Table 54. Germany: Dermatology OTC Medications Market, by Dermatitis – Revenue and Forecast to 2028 (USD Million)

Table 55. Germany: Dermatology OTC Medications Market, by Acne – Revenue and Forecast to 2028 (USD Million)

Table 56. Germany: Dermatology OTC Medications Market, by Psoriasis – Revenue and Forecast to 2028 (USD Million)

Table 57. Germany: Dermatology OTC Medications Market, by Fungal Disease – Revenue and Forecast to 2028 (USD Million)

Table 58. Germany: Dermatology OTC Medications Market, by Warts – Revenue and Forecast to 2028 (USD Million)

Table 59. Germany: Dermatology OTC Medications Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 60. Germany: Dermatology OTC Medications Market, by Offline Distribution – Revenue and Forecast to 2028 (USD Million)

Table 61. France: Dermatology OTC Medications Market, by Product Type – Revenue and Forecast to 2028 (USD Million)

Table 62. France: Dermatology OTC Medications Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)

Table 63. France: Dermatology OTC Medications Market, by Indication – Revenue and Forecast to 2028 (USD Million)

Table 64. France: Dermatology OTC Medications Market, by Dermatitis – Revenue and Forecast to 2028 (USD Million)

Table 65. France: Dermatology OTC Medications Market, by Acne – Revenue and Forecast to 2028 (USD Million)

Table 66. France: Dermatology OTC Medications Market, by Psoriasis – Revenue and Forecast to 2028 (USD Million)

Table 67. France: Dermatology OTC Medications Market, by Fungal Disease – Revenue and Forecast to 2028 (USD Million)

Table 68. France: Dermatology OTC Medications Market, by Warts – Revenue and Forecast to 2028 (USD Million)

Table 69. France: Dermatology OTC Medications Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 70. France: Dermatology OTC Medications Market, by Offline Distribution – Revenue and Forecast to 2028 (USD Million)

Table 71. UK: Dermatology OTC Medications Market, by Product Type – Revenue and Forecast to 2028 (USD Million)

Table 72. UK: Dermatology OTC Medications Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)

Table 73. UK: Dermatology OTC Medications Market, by Indication – Revenue and Forecast to 2028 (USD Million)

Table 74. UK: Dermatology OTC Medications Market, by Dermatitis – Revenue and Forecast to 2028 (USD Million)

Table 75. UK: Dermatology OTC Medications Market, by Acne – Revenue and Forecast to 2028 (USD Million)

Table 76. UK: Dermatology OTC Medications Market, by Psoriasis – Revenue and Forecast to 2028 (USD Million)

Table 77. UK: Dermatology OTC Medications Market, by Fungal Disease – Revenue and Forecast to 2028 (USD Million)

Table 78. UK: Dermatology OTC Medications Market, by Warts – Revenue and Forecast to 2028 (USD Million)

Table 79. UK: Dermatology OTC Medications Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 80. UK: Dermatology OTC Medications Market, by Offline Distribution – Revenue and Forecast to 2028 (USD Million)

Table 81. Italy: Dermatology OTC Medications Market, by Product Type – Revenue and Forecast to 2028 (USD Million)

Table 82. Italy: Dermatology OTC Medications Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)

Table 83. Italy: Dermatology OTC Medications Market, by Indication – Revenue and Forecast to 2028 (USD Million)

Table 84. Italy: Dermatology OTC Medications Market, by Dermatitis – Revenue and Forecast to 2028 (USD Million)

Table 85. Italy: Dermatology OTC Medications Market, by Acne – Revenue and Forecast to 2028 (USD Million)

Table 86. Italy: Dermatology OTC Medications Market, by Psoriasis – Revenue and Forecast to 2028 (USD Million)

Table 87. Italy: Dermatology OTC Medications Market, by Fungal Disease – Revenue and Forecast to 2028 (USD Million)

Table 88. Italy: Dermatology OTC Medications Market, by Warts – Revenue and Forecast to 2028 (USD Million)

Table 89. Italy: Dermatology OTC Medications Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 90. Italy: Dermatology OTC Medications Market, by Offline Distribution – Revenue and Forecast to 2028 (USD Million)

Table 91. Spain: Dermatology OTC Medications Market, by Product Type – Revenue and Forecast to 2028 (USD Million)

Table 92. Spain: Dermatology OTC Medications Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)

Table 93. Spain: Dermatology OTC Medications Market, by Indication – Revenue and Forecast to 2028 (USD Million)

Table 94. Spain: Dermatology OTC Medications Market, by Dermatitis – Revenue and Forecast to 2028 (USD Million)

Table 95. Spain: Dermatology OTC Medications Market, by Acne – Revenue and Forecast to 2028 (USD Million)

Table 96. Spain: Dermatology OTC Medications Market, by Psoriasis – Revenue and Forecast to 2028 (USD Million)

Table 97. Spain: Dermatology OTC Medications Market, by Fungal Disease – Revenue and Forecast to 2028 (USD Million)

Table 98. Spain: Dermatology OTC Medications Market, by Warts – Revenue and Forecast to 2028 (USD Million)

Table 99. Spain: Dermatology OTC Medications Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 100. Spain: Dermatology OTC Medications Market, by Offline Distribution – Revenue and Forecast to 2028 (USD Million)

Table 101. Rest of Europe: Dermatology OTC Medications Market, by Product Type – Revenue and Forecast to 2028 (USD Million)

Table 102. Rest of Europe: Dermatology OTC Medications Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)

Table 103. Rest of Europe: Dermatology OTC Medications Market, by Indication – Revenue and Forecast to 2028 (USD Million)

Table 104. Rest of Europe: Dermatology OTC Medications Market, by Dermatitis – Revenue and Forecast to 2028 (USD Million)

Table 105. Rest of Europe: Dermatology OTC Medications Market, by Acne – Revenue and Forecast to 2028 (USD Million)

Table 106. Rest of Europe: Dermatology OTC Medications Market, by Psoriasis – Revenue and Forecast to 2028 (USD Million)

Table 107. Rest of Europe: Dermatology OTC Medications Market, by Fungal Disease – Revenue and Forecast to 2028 (USD Million)

Table 108. Rest of Europe: Dermatology OTC Medications Market, by Warts – Revenue and Forecast to 2028 (USD Million)

Table 109. Rest of Europe: Dermatology OTC Medications Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 110. Rest of Europe: Dermatology OTC Medications Market, by Offline Distribution – Revenue and Forecast to 2028 (USD Million)

Table 111. Asia Pacific: Dermatology OTC Medications Market, by Product Type – Revenue and Forecast to 2028 (USD Million)

Table 112. Asia Pacific: Dermatology OTC Medications Market, By Route of Administration – Revenue and Forecast to 2028 (USD Million)

Table 113. Asia Pacific: Dermatology OTC Medications Market, By Indication – Revenue and Forecast to 2028 (USD Million)

Table 114. Asia Pacific: Dermatology OTC Medications Market, by Acne Indication – Revenue and Forecast to 2028 (USD Million)

Table 115. Asia Pacific: Dermatology OTC Medications Market, by Dermatitis Indication – Revenue and Forecast to 2028 (USD Million)

Table 116. Asia Pacific: Dermatology OTC Medications Market, by Fungal Diseases Indication – Revenue and Forecast to 2028 (USD Million)

Table 117. Asia Pacific: Dermatology OTC Medications Market, by Psoriasis Indication – Revenue and Forecast to 2028 (USD Million)

Table 118. Asia Pacific: Dermatology OTC Medications Market, by Warts Indication – Revenue and Forecast to 2028 (USD Million)

Table 119. Asia Pacific: Dermatology OTC Medications Market, By Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 120. Asia Pacific: Dermatology OTC Medications Market, by Offline Distribution – Revenue and Forecast to 2028 (USD Million)

Table 121. China: Dermatology OTC Medications Market, by Product Type – Revenue and Forecast to 2028 (USD Million)

Table 122. China: Dermatology OTC Medications Market, By Route of Administration – Revenue and Forecast to 2028 (USD Million)

Table 123. China: Dermatology OTC Medications Market, By Indication – Revenue and Forecast to 2028 (USD Million)

Table 124. China: Dermatology OTC Medications Market, by Acne Indication – Revenue and Forecast to 2028 (USD Million)

Table 125. China: Dermatology OTC Medications Market, by Dermatitis Indication – Revenue and Forecast to 2028 (USD Million)

Table 126. China: Dermatology OTC Medications Market, by Fungal Diseases Indication – Revenue and Forecast to 2028 (USD Million)

Table 127. China: Dermatology OTC Medications Market, by Psoriasis Indication – Revenue and Forecast to 2028 (USD Million)

Table 128. China: Dermatology OTC Medications Market, by Warts Indication – Revenue and Forecast to 2028 (USD Million)

Table 129. China: Dermatology OTC Medications Market, By Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 130. China: Dermatology OTC Medications Market, by Offline Distribution – Revenue and Forecast to 2028 (USD Million)

Table 131. Japan: Dermatology OTC Medications Market, by Product Type – Revenue and Forecast to 2028 (USD Million)

Table 132. Japan: Dermatology OTC Medications Market, By Route of Administration – Revenue and Forecast to 2028 (USD Million)

Table 133. Japan: Dermatology OTC Medications Market, By Indication – Revenue and Forecast to 2028 (USD Million)

Table 134. Japan: Dermatology OTC Medications Market, by Acne Indication – Revenue and Forecast to 2028 (USD Million)

Table 135. Japan: Dermatology OTC Medications Market, by Dermatitis Indication – Revenue and Forecast to 2028 (USD Million)

Table 136. Japan: Dermatology OTC Medications Market, by Fungal Diseases Indication – Revenue and Forecast to 2028 (USD Million)

Table 137. Japan: Dermatology OTC Medications Market, by Psoriasis Indication – Revenue and Forecast to 2028 (USD Million)

Table 138. Japan: Dermatology OTC Medications Market, by Warts Indication – Revenue and Forecast to 2028 (USD Million)

Table 139. Japan: Dermatology OTC Medications Market, By Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 140. Japan: Dermatology OTC Medications Market, by Offline Distribution – Revenue and Forecast to 2028 (USD Million)

Table 141. India: Dermatology OTC Medications Market, by Product Type – Revenue and Forecast to 2028 (USD Million)

Table 142. India: Dermatology OTC Medications Market, By Route of Administration – Revenue and Forecast to 2028 (USD Million)

Table 143. India: Dermatology OTC Medications Market, By Indication – Revenue and Forecast to 2028 (USD Million)

Table 144. India: Dermatology OTC Medications Market, by Acne Indication – Revenue and Forecast to 2028 (USD Million)

Table 145. India: Dermatology OTC Medications Market, by Dermatitis Indication – Revenue and Forecast to 2028 (USD Million)

Table 146. India: Dermatology OTC Medications Market, by Fungal Diseases Indication – Revenue and Forecast to 2028 (USD Million)

Table 147. India: Dermatology OTC Medications Market, by Psoriasis Indication – Revenue and Forecast to 2028 (USD Million)

Table 148. India: Dermatology OTC Medications Market, by Warts Indication – Revenue and Forecast to 2028 (USD Million)

Table 149. India: Dermatology OTC Medications Market, By Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 150. India: Dermatology OTC Medications Market, by Offline Distribution – Revenue and Forecast to 2028 (USD Million)

Table 151. Australia: Dermatology OTC Medications Market, by Product Type – Revenue and Forecast to 2028 (USD Million)

Table 152. Australia: Dermatology OTC Medications Market, By Route of Administration – Revenue and Forecast to 2028 (USD Million)

Table 153. Australia: Dermatology OTC Medications Market, By Indication – Revenue and Forecast to 2028 (USD Million)

Table 154. Australia: Dermatology OTC Medications Market, by Acne Indication – Revenue and Forecast to 2028 (USD Million)

Table 155. Australia: Dermatology OTC Medications Market, by Dermatitis Indication – Revenue and Forecast to 2028 (USD Million)

Table 156. Australia: Dermatology OTC Medications Market, by Fungal Diseases Indication – Revenue and Forecast to 2028 (USD Million)

Table 157. Australia: Dermatology OTC Medications Market, by Psoriasis Indication – Revenue and Forecast to 2028 (USD Million)

Table 158. Australia: Dermatology OTC Medications Market, by Warts Indication – Revenue and Forecast to 2028 (USD Million)

Table 159. Australia: Dermatology OTC Medications Market, By Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 160. Australia: Dermatology OTC Medications Market, by Offline Distribution – Revenue and Forecast to 2028 (USD Million)

Table 161. South Korea: Dermatology OTC Medications Market, by Product Type – Revenue and Forecast to 2028 (USD Million)

Table 162. South Korea: Dermatology OTC Medications Market, By Route of Administration – Revenue and Forecast to 2028 (USD Million)

Table 163. South Korea: Dermatology OTC Medications Market, By Indication – Revenue and Forecast to 2028 (USD Million)

Table 164. South Korea: Dermatology OTC Medications Market, by Acne Indication – Revenue and Forecast to 2028 (USD Million)

Table 165. South Korea: Dermatology OTC Medications Market, by Dermatitis Indication – Revenue and Forecast to 2028 (USD Million)

Table 166. South Korea: Dermatology OTC Medications Market, by Fungal Diseases Indication – Revenue and Forecast to 2028 (USD Million)

Table 167. South Korea: Dermatology OTC Medications Market, by Psoriasis Indication – Revenue and Forecast to 2028 (USD Million)

Table 168. South Korea: Dermatology OTC Medications Market, by Warts Indication – Revenue and Forecast to 2028 (USD Million)

Table 169. South Korea: Dermatology OTC Medications Market, By Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 170. South Korea: Dermatology OTC Medications Market, by Offline Distribution – Revenue and Forecast to 2028 (USD Million)

Table 171. Rest of Asia Pacific: Dermatology OTC Medications Market, by Product Type – Revenue and Forecast to 2028 (USD Million)

Table 172. Rest of Asia Pacific: Dermatology OTC Medications Market, By Route of Administration – Revenue and Forecast to 2028 (USD Million)

Table 173. Rest of Asia Pacific: Dermatology OTC Medications Market, By Indication – Revenue and Forecast to 2028 (USD Million)

Table 174. Rest of Asia Pacific: Dermatology OTC Medications Market, by Acne Indication – Revenue and Forecast to 2028 (USD Million)

Table 175. Rest of Asia Pacific: Dermatology OTC Medications Market, by Dermatitis Indication – Revenue and Forecast to 2028 (USD Million)

Table 176. Rest of Asia Pacific: Dermatology OTC Medications Market, by Fungal Diseases Indication – Revenue and Forecast to 2028 (USD Million)

Table 177. Rest of Asia Pacific: Dermatology OTC Medications Market, by Psoriasis Indication – Revenue and Forecast to 2028 (USD Million)

Table 178. Rest of Asia Pacific: Dermatology OTC Medications Market, by Warts Indication – Revenue and Forecast to 2028 (USD Million)

Table 179. Rest of Asia Pacific: Dermatology OTC Medications Market, By Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 180. Rest of Asia Pacific: Dermatology OTC Medications Market, by Offline Distribution – Revenue and Forecast to 2028 (USD Million)

Table 181. Middle East & Africa: Dermatology OTC Medications Market, by Product Type – Revenue and Forecast to 2028 (USD Million)

Table 182. Middle East & Africa: Dermatology OTC Medications Market, By Route of Administration – Revenue and Forecast to 2028 (USD Million)

Table 183. Middle East & Africa: Dermatology OTC Medications Market, By Indication – Revenue and Forecast to 2028 (USD Million)

Table 184. Middle East & Africa: Dermatology OTC Medications Market, by Acne Indication – Revenue and Forecast to 2028 (USD Million)

Table 185. Middle East & Africa: Dermatology OTC Medications Market, by Dermatitis Indication – Revenue and Forecast to 2028 (USD Million)

Table 186. Middle East & Africa: Dermatology OTC Medications Market, by Fungal Diseases Indication – Revenue and Forecast to 2028 (USD Million)

Table 187. Middle East & Africa: Dermatology OTC Medications Market, by Psoriasis Indication – Revenue and Forecast to 2028 (USD Million)

Table 188. Middle East & Africa: Dermatology OTC Medications Market, by Warts Indication – Revenue and Forecast to 2028 (USD Million)

Table 189. Middle East & Africa: Dermatology OTC Medications Market, By Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 190. Middle East & Africa: Dermatology OTC Medications Market, by Offline Distribution – Revenue and Forecast to 2028 (USD Million)

Table 191. UAE: Dermatology OTC Medications Market, by Product Type – Revenue and Forecast to 2028 (USD Million)

Table 192. UAE: Dermatology OTC Medications Market, By Route of Administration – Revenue and Forecast to 2028 (USD Million)

Table 193. UAE: Dermatology OTC Medications Market, By Indication – Revenue and Forecast to 2028 (USD Million)

Table 194. UAE: Dermatology OTC Medications Market, by Acne Indication – Revenue and Forecast to 2028 (USD Million)

Table 195. UAE: Dermatology OTC Medications Market, by Dermatitis Indication – Revenue and Forecast to 2028 (USD Million).

Table 196. UAE: Dermatology OTC Medications Market, by Fungal Diseases Indication – Revenue and Forecast to 2028 (USD Million)

Table 197. UAE: Dermatology OTC Medications Market, by Psoriasis Indication – Revenue and Forecast to 2028 (USD Million)

Table 198. UAE: Dermatology OTC Medications Market, by Warts Indication – Revenue and Forecast to 2028 (USD Million)

Table 199. UAE: Dermatology OTC Medications Market, By Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 200. UAE: Dermatology OTC Medications Market, by Offline Distribution – Revenue and Forecast to 2028 (USD Million)

Table 201. Saudi Arabia: Dermatology OTC Medications Market, by Product Type – Revenue and Forecast to 2028 (USD Million)

Table 202. Saudi Arabia: Dermatology OTC Medications Market, By Route of Administration – Revenue and Forecast to 2028 (USD Million)

Table 203. Saudi Arabia: Dermatology OTC Medications Market, By Indication – Revenue and Forecast to 2028 (USD Million)

Table 204. Saudi Arabia: Dermatology OTC Medications Market, by Acne Indication – Revenue and Forecast to 2028 (USD Million)

Table 205. Saudi Arabia: Dermatology OTC Medications Market, by Dermatitis Indication – Revenue and Forecast to 2028 (USD Million)

Table 206. Saudi Arabia: Dermatology OTC Medications Market, by Fungal Diseases Indication – Revenue and Forecast to 2028 (USD Million)

Table 207. Saudi Arabia: Dermatology OTC Medications Market, by Psoriasis Indication – Revenue and Forecast to 2028 (USD Million)

Table 208. Saudi Arabia: Dermatology OTC Medications Market, by Warts Indication – Revenue and Forecast to 2028 (USD Million)

Table 209. Saudi Arabia: Dermatology OTC Medications Market, By Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 210. Saudi Arabia: Dermatology OTC Medications Market, by Offline Distribution – Revenue and Forecast to 2028 (USD Million)

Table 211. South Africa: Dermatology OTC Medications Market, by Product Type – Revenue and Forecast to 2028 (USD Million)

Table 212. South Africa: Dermatology OTC Medications Market, By Route of Administration – Revenue and Forecast to 2028 (USD Million)

Table 213. South Africa: Dermatology OTC Medications Market, By Indication – Revenue and Forecast to 2028 (USD Million)

Table 214. South Africa: Dermatology OTC Medications Market, by Acne Indication – Revenue and Forecast to 2028 (USD Million)

Table 215. South Africa: Dermatology OTC Medications Market, by Dermatitis Indication – Revenue and Forecast to 2028 (USD Million)

Table 216. South Africa: Dermatology OTC Medications Market, by Fungal Diseases Indication – Revenue and Forecast to 2028 (USD Million)

Table 217. South Africa: Dermatology OTC Medications Market, by Psoriasis Indication – Revenue and Forecast to 2028 (USD Million)

Table 218. South Africa: Dermatology OTC Medications Market, by Warts Indication – Revenue and Forecast to 2028 (USD Million)

Table 219. South Africa: Dermatology OTC Medications Market, By Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 220. South Africa: Dermatology OTC Medications Market, by Offline Distribution – Revenue and Forecast to 2028 (USD Million)

Table 221. Rest of Middle East and Africa: Dermatology OTC Medications Market, by Product Type – Revenue and Forecast to 2028 (USD Million)

Table 222. Rest of Middle East and Africa: Dermatology OTC Medications Market, By Route of Administration – Revenue and Forecast to 2028 (USD Million)

Table 223. Rest of Middle East and Africa: Dermatology OTC Medications Market, By Indication – Revenue and Forecast to 2028 (USD Million)

Table 224. Rest of Middle East and Africa: Dermatology OTC Medications Market, by Acne Indication – Revenue and Forecast to 2028 (USD Million)

Table 225. Rest of Middle East and Africa: Dermatology OTC Medications Market, by Dermatitis Indication – Revenue and Forecast to 2028 (USD Million)

Table 226. Rest of Middle East and Africa: Dermatology OTC Medications Market, by Fungal Diseases Indication – Revenue and Forecast to 2028 (USD Million)

Table 227. Rest of Middle East and Africa: Dermatology OTC Medications Market, by Psoriasis Indication – Revenue and Forecast to 2028 (USD Million)

Table 228. Rest of Middle East and Africa: Dermatology OTC Medications Market, by Warts Indication – Revenue and Forecast to 2028 (USD Million)

Table 229. Rest of Middle East and Africa: Dermatology OTC Medications Market, By Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 230. Rest of Middle East and Africa: Dermatology OTC Medications Market, by Offline Distribution – Revenue and Forecast to 2028 (USD Million)

Table 231. South & Central America: Dermatology OTC Medications Market, by Product Type – Revenue and Forecast to 2028 (USD Million)

Table 232. South & Central America: Dermatology OTC Medications Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)

Table 233. North America: Dermatology OTC Medications Market, by Indication – Revenue and Forecast to 2028 (USD Million)

Table 234. South & Central America: Dermatology OTC Medications Market, by Dermatitis – Revenue and Forecast to 2028 (USD Million)

Table 235. North America: Dermatology OTC Medications Market, by Acne – Revenue and Forecast to 2028 (USD Million)

Table 236. South & Central America: Dermatology OTC Medications Market, by Psoriasis – Revenue and Forecast to 2028 (USD Million)

Table 237. South & Central America: Dermatology OTC Medications Market, by Fungal Disease – Revenue and Forecast to 2028 (USD Million)

Table 238. South & Central America: Dermatology OTC Medications Market, by Warts – Revenue and Forecast to 2028 (USD Million)

Table 239. South & Central America: Dermatology OTC Medications Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 240. South & Central America: Dermatology OTC Medications Market, by Offline Distribution – Revenue and Forecast to 2028 (USD Million)

Table 241. Brazil: Dermatology OTC Medications Market, by Product Type – Revenue and Forecast to 2028 (USD Million)

Table 242. Brazil: Dermatology OTC Medications Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)

Table 243. Brazil: Dermatology OTC Medications Market, by Indication – Revenue and Forecast to 2028 (USD Million)

Table 244. Brazil: Dermatology OTC Medications Market, by Dermatitis – Revenue and Forecast to 2028 (USD Million)

Table 245. Brazil: Dermatology OTC Medications Market, by Acne – Revenue and Forecast to 2028 (USD Million)

Table 246. Brazil: Dermatology OTC Medications Market, by Psoriasis – Revenue and Forecast to 2028 (USD Million)

Table 247. Brazil: Dermatology OTC Medications Market, by Fungal Disease – Revenue and Forecast to 2028 (USD Million)

Table 248. Brazil: Dermatology OTC Medications Market, by Warts – Revenue and Forecast to 2028 (USD Million)

Table 249. Brazil: Dermatology OTC Medications Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 250. Brazil: Dermatology OTC Medications Market, by Offline Distribution – Revenue and Forecast to 2028 (USD Million)

Table 251. Argentina: Dermatology OTC Medications Market, by Product Type – Revenue and Forecast to 2028 (USD Million)

Table 252. Argentina: Dermatology OTC Medications Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)

Table 253. Argentina: Dermatology OTC Medications Market, by Indication – Revenue and Forecast to 2028 (USD Million)

Table 254. Argentina: Dermatology OTC Medications Market, by Dermatitis – Revenue and Forecast to 2028 (USD Million)

Table 255. Argentina: Dermatology OTC Medications Market, by Acne – Revenue and Forecast to 2028 (USD Million)

Table 256. Argentina: Dermatology OTC Medications Market, by Psoriasis – Revenue and Forecast to 2028 (USD Million)

Table 257. Argentina: Dermatology OTC Medications Market, by Fungal Disease – Revenue and Forecast to 2028 (USD Million)

Table 258. Argentina: Dermatology OTC Medications Market, by Warts – Revenue and Forecast to 2028 (USD Million)

Table 259. Argentina: Dermatology OTC Medications Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 260. Argentina: Dermatology OTC Medications Market, by Offline Distribution – Revenue and Forecast to 2028 (USD Million)

Table 261. Rest of South & Central America: Dermatology OTC Medications Market, by Product Type – Revenue and Forecast to 2028 (USD Million)

Table 262. Rest of South & Central America: Dermatology OTC Medications Market, by Route of Administration – Revenue and Forecast to 2028 (USD Million)

Table 263. Rest of South & Central America: Dermatology OTC Medications Market, by Indication – Revenue and Forecast to 2028 (USD Million)

Table 264. Rest of South & Central America: Dermatology OTC Medications Market, by Dermatitis – Revenue and Forecast to 2028 (USD Million)

Table 265. Rest of South & Central America: Dermatology OTC Medications Market, by Acne – Revenue and Forecast to 2028 (USD Million)

Table 266. Rest of South & Central America: Dermatology OTC Medications Market, by Psoriasis – Revenue and Forecast to 2028 (USD Million)

Table 267. Rest of South & Central America: Dermatology OTC Medications Market, by Fungal Disease – Revenue and Forecast to 2028 (USD Million)

Table 268. Rest of South & Central America: Dermatology OTC Medications Market, by Warts – Revenue and Forecast to 2028 (USD Million)

Table 269. Rest of South & Central America: Dermatology OTC Medications Market, by Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 270. Rest of South & Central America: Dermatology OTC Medications Market, by Offline Distribution – Revenue and Forecast to 2028 (USD Million)

Table 271. Recent Inorganic Growth Strategies in the Dermatology OTC Medications Market

Table 272. Recent Organic Growth Strategies in the Dermatology OTC Medications Market

Table 273. Glossary of Terms, Dermatology OTC Medications Market

LIST OF FIGURES

Figure 1. Dermatology OTC Medications Market Segmentation

Figure 2. Dermatology OTC Medications Market, By Region

Figure 3. Global Dermatology OTC Medications Market Overview

Figure 4. Creams and Ointments Segment Held Largest Share of Product Type Segment in Dermatology OTC Medications Market

Figure 5. Asia Pacific is Expected to Show Remarkable Growth During the Forecast Period

Figure 6. Dermatology OTC Medications Market, by Geography (US$ Million)

Figure 7. Global Dermatology OTC Medications Market- Leading Country Markets (US$ Million)

Figure 8. Global Dermatology OTC Medications Market, Industry Landscape

Figure 9. North America: PEST Analysis

Figure 10. Europe: PEST Analysis

Figure 11. Asia Pacific: PEST Analysis

Figure 12. Middle East And Africa: PEST Analysis

Figure 13. South & Central America: PEST Analysis

Figure 14. Experts Opinion

Figure 15. Dermatology OTC Medications Market Impact Analysis of Drivers and Restraints

Figure 16. Global Dermatology OTC Medications Market– Revenue Forecast and Analysis – 2021 - 2028

Figure 17. Global Dermatology OTC Medications Market – By Geography Forecast and Analysis – 2021 - 2028

Figure 18. Market Positioning of Key Players in Global Dermatology OTC Medications Market

Figure 19. Dermatology OTC Medications Market Share by Product Type, 2021 & 2028 (%)

Figure 20. Tablets and Capsules Market Revenue and Forecasts to 2028 (US$ million)

Figure 21. Gels Market Revenue and Forecasts to 2028 (US$ million)

Figure 22. Creams and Ointments Market Revenue and Forecasts to 2028 (US$ million)

Figure 23. Others Market Revenue and Forecasts to 2028 (US$ million)

Figure 24. Dermatology OTC Medications market Share, by Route of Administration, 2021 and 2028 (%)

Figure 25. Topical: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

Figure 26. Oral: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

Figure 27. Dermatology OTC Medications Market Share, by Indication, 2021 and 2028 (%)

Figure 28. Dermatitis: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

Figure 29. Atopic Dermatitis: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

Figure 30. Contact Dermatitis: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

Figure 31. Others: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

Figure 32. Acne: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

Figure 33. Non-Inflammatory Acne: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

Figure 34. Inflammatory Acne: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

Figure 35. Psoriasis: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

Figure 36. Plaque Psoriasis: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

Figure 37. Guttate Psoriasis: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

Figure 38. Others: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

Figure 39. Skin Bleaching: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

Figure 40. Fungal Disease: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

Figure 41. Athlete's Foot: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

Figure 42. Ringworm: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

Figure 43. Fungal Nail Infections: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

Figure 44. Others: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

Figure 45. Warts: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

Figure 46. Common Warts: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

Figure 47. Flat Warts: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

Figure 48. Others: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

Figure 49. Others: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

Figure 50. Dermatology OTC Medications market Share, by Distribution Channel, 2021 and 2028 (%)

Figure 51. Online Distribution: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

Figure 52. Offline Distribution: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

Figure 53. Retail and Hospital Pharmacies: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

Figure 54. Super and Hyper Markets: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

Figure 55. North America: Dermatology OTC Medications Market, by Key Country – Revenue (2021) (USD Million)

Figure 56. North America: Dermatology OTC Medications Market Revenue and Forecast to 2028 (USD Million)

Figure 57. North America Dermatology OTC Medications Market, by Country, 2021 & 2028 (%)

Figure 58. US: Dermatology OTC Medications Market – Revenue and Forecast to 2028 (USD Million)

Figure 59. Canada: Dermatology OTC Medications Market – Revenue and Forecast to 2028 (USD Million)

Figure 60. Mexico: Dermatology OTC Medications Market – Revenue and Forecast to 2028 (USD Million)

Figure 61. Europe: Dermatology OTC Medications Market, by Key Country – Revenue (2021) (USD Million)

Figure 62. Europe: Dermatology OTC Medications Market Revenue and Forecast to 2028 (USD Million)

Figure 63. Europe: Dermatology OTC Medications Market, by Country, 2021 & 2028 (%)

Figure 64. Germany: Dermatology OTC Medications Market – Revenue and Forecast to 2028 (USD Million)

Figure 65. France: Dermatology OTC Medications Market – Revenue and Forecast to 2028 (USD Million)

Figure 66. UK: Dermatology OTC Medications Market – Revenue and Forecast to 2028 (USD Million)

Figure 67. Italy: Dermatology OTC Medications Market – Revenue and Forecast to 2028 (USD Million)

Figure 68. Spain: Dermatology OTC Medications Market – Revenue and Forecast to 2028 (USD Million)

Figure 69. Rest of Europe: Dermatology OTC Medications Market – Revenue and Forecast to 2028 (USD Million)

Figure 70. Asia Pacific: Dermatology OTC Medications Market, by Key Country – Revenue (2021) (USD Million)

Figure 71. Asia Pacific Dermatology OTC Medications Market Revenue and Forecast to 2028 (USD Million)

Figure 72. Asia Pacific: Dermatology OTC Medications Market, by Country, 2021 & 2028 (%)

Figure 73. China: Dermatology OTC Medications Market – Revenue and Forecast to 2028 (USD Million)

Figure 74. Japan: Dermatology OTC Medications Market – Revenue and Forecast to 2028 (USD Million)

Figure 75. India: Dermatology OTC Medications Market – Revenue and Forecast to 2028 (USD Million)

Figure 76. Australia: Dermatology OTC Medications Market – Revenue and Forecast to 2028 (USD Million)

Figure 77. South Korea: Dermatology OTC Medications Market – Revenue and Forecast to 2028 (USD Million)

Figure 78. Rest of Asia Pacific: Dermatology OTC Medications Market – Revenue and Forecast to 2028 (USD Million)

Figure 79. Middle East & Africa Dermatology OTC Medications Market Revenue Overview, by Country, 2021 (US$ Million)

Figure 80. Middle East & Africa Dermatology OTC Medications Market Revenue and Forecasts to 2028 (US$ Million)

Figure 81. Middle East & Africa Dermatology OTC Medications Market Revenue and Forecasts to 2028, By Country (%)

Figure 82. UAE: Dermatology OTC Medications Market Revenue and Forecasts to 2028 (US$ Million)

Figure 83. Saudi Arabia: Dermatology OTC Medications Market Revenue and Forecasts to 2028 (US$ Million)

Figure 84. South Africa: Dermatology OTC Medications Market Revenue and Forecasts to 2028 (US$ Million)

Figure 85. Rest of Middle East and Africa: Dermatology OTC Medications Market Revenue and Forecasts to 2028 (US$ Million)

Figure 86. South & Central America: Dermatology OTC Medications Market, by Key Country – Revenue (2021) (USD Million)

Figure 87. North America: Dermatology OTC Medications Market Revenue and Forecast to 2028 (USD Million)

Figure 88. South & Central America: Dermatology OTC Medications Market, by Country, 2021 & 2028 (%)

Figure 89. US: Dermatology OTC Medications Market – Revenue and Forecast to 2028 (USD Million)

Figure 90. Argentina: Dermatology OTC Medications Market – Revenue and Forecast to 2028 (USD Million)

Figure 91. Rest of South & Central America: Dermatology OTC Medications Market – Revenue and Forecast to 2028 (USD Million)

Figure 92. Impact of COVID-19 Pandemic in North American Country Markets

Figure 93. Impact of COVID-19 Pandemic in European Country Markets

Figure 94. Impact of COVID-19 Pandemic in Asia Pacific Country Markets

Figure 95. Impact of COVID-19 Pandemic in Middle East and Africa Country Markets

Figure 96. Impact Of COVID-19 Pandemic In South & Central America Market

Figure 97. Growth Strategies in the Dermatology OTC Medications Market , 2021-2028

The List of Companies - Dermatology OTC Medications Market

  1. Bausch Health Companies Inc.
  2. Perrigo Company plc
  3. Bayer AG
  4. Viatris Inc.
  5. Johnson and Johnson Services, Inc.
  6. LEO Pharma A/S
  7. GlaxoSmithKline plc.
  8. Galderma
  9. Dr. Reddy's Laboratories
  10. Acella Pharmaceuticals, LLC

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • 3.1 Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • 3.2 Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • 3.3 Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • 3.4 Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Trends and growth analysis reports related to Life Sciences : READ MORE..